眼 (JP Patent Analysis Report)
The Technical Field "眼" had 49 patent application filings in the most recent period (2023-01-01 to 2023-02-28). This is a significantly decreased of -102 filings (-67.5%) over 151 they had in the same period of the previous year (2022-01-01 to 2022-02-28). This report also includes technical terms related to " 眼部 " in the search set.
The highest number of filings in 2017 with 2,114 cases, and their lowest number in 2022 with 1,050 cases.
The mean of the number of filings over the last 5 years (2018 to 2023, 8,140 cases in total) is 1,357, and the median is 1,481. The coefficient of variation (standard deviation/mean) is 0.5, and there have been big fluctuations in the number of filings from year to year.
| Index | Value |
|---|---|
| Average | 1,357 patents |
| Std Dev | 629 |
| COV | 0.5 |
| Year | Cases | YOY |
|---|---|---|
| 2022 year | 1,050 cases | -23.64 % |
| 2021 year | 1,375 cases | -13.36 % |
| 2020 year | 1,587 cases | -20.05 % |
This report provides the latest patent analysis information (the IP landscape, including a patent map) on the patent search results of the JP patent database for 眼 for the period of the last 10 years (2014-01-01 to 2024-10-31). You can compare the information in this report with the trends in your competitors’ patent filings and technologies, and use it to search for important patents.
This service provides, free of charge, a patent analysis report based on the latest patent data (Japanese, U.S., European, and PCT application publications) for use in patent searches, patent analysis, and IP landscaping. The service is offered by "Patent Integration" a firm specializing in patent search/patent analysis.
This report includes basic information to help you understand the IP strategy and management of 眼, such as changes in the number of patents/patent applications they have filed, comparisons of the numbers of patents/patent applications filed by their peers and competitors, their top coapplicants (joint research partners, alliance partners), and their most important patents. It can be used in various intellectual property business operations such as IP landscaping, patent search/patent analysis, preparation of intellectual property business evaluation reports, selection of M&A candidates, and selection of alliance partners.
He is a patent attorney at a patent office. He specializes in invention counseling, patent filing, and intellectual property strategies for start-up companies and new businesses in the fields of software, information technology and artificial intelligence. He runs a patent course for beginners on Udemy, an online course provider.
After studying physics at the University of Tokyo as a doctoral student, he was engaged in intellectual property analysis and technology trend research as an in-house patent attorney at a precision equipment manufacturer and at Toyota Central R&D Labs. Inc..
Introduction
The concept of the "IP landscape" (IPL) has been attracting attention recently.
An IP landscape is not limited to patent information, but also integrates and analyzes business information (e.g., non-patent information such as papers, news releases, stock information, and market information). Intellectual-property-based business management is realized through the analysis of intellectual property information applied to the formulation of management strategies and business strategies. This is a comprehensive approach that includes but not limited to planning of open and closed strategies, selecting M&A candidates, searching for alliance partners, and formulating intellectual property strategies, through the exploitation of intellectual property information.
IP landscaping usually includes patent search and patent analysis. In patent search and patent analysis, it is important to grasp the market position of each company and the overall technological trends and development trends for each technology. More specifically, it is important to understand what intellectual property your own company and other companies hold, what the strengths and weaknesses of other companies are, and how other companies are trying to exploit their intellectual property. In other words, it is important to understand both the business strategy and the intellectual property strategy of each company.
After reading this search report, you may be interested in more detailed patent searches and patent analysis. We offer a service called Patent Integration, which is an integrated patent search and patent analysis service. With reasonable pricing and a simple user interface such that even beginners can quickly search for and analyze patent information by company or technology from a web browser, please consider using it for detailed patent searches, patent analysis, and IP landscaping.
Patent Integration has a patent-landscaping function that can visually represent a set of tens of thousands of patents/patent applications. This allows you to convincingly show the technical positions of your company and its competitors to your management and business strategists in order to formulate management strategies and business strategies.
眼, Changes in the Number of JP Patents/Patent Applications
The changes in the number of patent filings of 眼 over the last 20 years (JP) are shown below.
The change in the number of patents/patent applications is the most basic index in patent analysis. By examining the change in the number of patents/patent applications, you can see the status of technological development and R&D focus for each company or technology. It should be noted that since there is a one and a half year lag between the filing and the laying open of patent applications, it is not possible to analyze the situation more recently than one and half years prior to the present.
In this report, you can only see the change in the number of patents/patent applications by company or technology, whereas Patent Integration allows you to quickly compare the number of patent applications with your competitors in each technical field by cross-referencing with other keywords and patent classifications.
Search Set (Analysis Patents)
This patent analysis report was created for a patent search set of 15,937 cases retrieved by applying the following search formula and analysis period to the following patent database. Patent information such as a patent analysis result, a patent map, and a patent landscape can be freely used for patent searches, analysis, and work on intellectual property strategies, including IP landscaping.
眼
Same industry / competition company information (JP)
The number of patents and changes in the number of patents of other companies (competitors) in the same industry as 眼 are shown below.
Comparison of changes in the number of patents with peers and competitors is an important analytical index for understanding the intellectual property strategies of each company. By checking the transition of the number of patents for each company / competitor, you can check the status of focus on technology development and R&D for each company / technology.
It should be noted that patents have a time lag of one and a half years from filing to publication, so it is not possible to analyze the situation more recent than one and a half years.
If you want to find out more information, " Patent Integration , You can compare the number of patent applications with competitors in each technical field in a short time by multiplying with other keywords and patent classifications.Please use it for more detailed patent information analysis such as selection of M&A candidate destinations and alliance destinations.
Trends in filing of joint patent applications in the last 3 years (2022 to 2024).
Comparing the number of applications of each company, キヤノン株式会社 has the highest number of joint applications in the last in the last 3 years (2022 to 2024) with 70 cases, followed by アルコンインコーポレイティド with 60 cases.
| Name | Cases |
|---|---|
| キヤノン株式会社 | 70 cases |
| アルコンインコーポレイティド | 60 cases |
| 株式会社トプコン | 56 cases |
| 株式会社ニデック | 43 cases |
| セイコーエプソン株式会社 | 10 cases |
| マジックリープインコーポレイテッド | 5 cases |
| ノバルティスアーゲー | 4 cases |
Trends in filing of joint patent applications for the target period (2014 to 2024).
Comparing the number of applications of each company, 株式会社トプコン has the highest number of joint applications in the last for the target period (2014 to 2024) with 664 cases, followed by キヤノン株式会社 with 489 cases.
| Name | Cases |
|---|---|
| 株式会社トプコン | 664 cases |
| キヤノン株式会社 | 489 cases |
| 株式会社ニデック | 475 cases |
| マジックリープインコーポレイテッド | 475 cases |
| アルコンインコーポレイティド | 398 cases |
| セイコーエプソン株式会社 | 230 cases |
| ノバルティスアーゲー | 167 cases |
| ソニーグループ株式会社 | 162 cases |
| 株式会社ニコン | 76 cases |
| オリンパス株式会社 | 21 cases |
| パナソニックホールディングス株式会社 | 6 cases |
Same industry / competition company, Change in the Number of JP Patents
Below is a patent map showing changes in the number of applications for JP patents of 11 companies in the same industry over the past 20 years.
Top company information (JP)
The number of patents and changes in the number of patents of other companies (competitors) in the same industry as 眼 are shown below.
Comparison of changes in the number of patents with peers and competitors is an important analytical index for understanding the intellectual property strategies of each company. By checking the transition of the number of patents for each company / competitor, you can check the status of focus on technology development and R&D for each company / technology.
It should be noted that patents have a time lag of one and a half years from filing to publication, so it is not possible to analyze the situation more recent than one and a half years.
If you want to find out more information, " Patent Integration , You can compare the number of patent applications with competitors in each technical field in a short time by multiplying with other keywords and patent classifications.Please use it for more detailed patent information analysis such as selection of M&A candidate destinations and alliance destinations.
Trends in filing of joint patent applications in the last 3 years (2022 to 2024).
Among the top coapplicants, キヤノン株式会社 has the highest number of joint applications in the last in the last 3 years (2022 to 2024) with 70 cases, followed by 株式会社トプコン with 56 cases.
| Name | Cases |
|---|---|
| キヤノン株式会社 | 70 cases |
| 株式会社トプコン | 56 cases |
| 株式会社ニデック | 43 cases |
| セイコーエプソン株式会社 | 10 cases |
Trends in filing of joint patent applications for the target period (2014 to 2024).
Among the top coapplicants, 株式会社トプコン has the highest number of joint applications in the last for the target period (2014 to 2024) with 664 cases, followed by キヤノン株式会社 with 489 cases.
| Name | Cases |
|---|---|
| 株式会社トプコン | 664 cases |
| キヤノン株式会社 | 489 cases |
| 株式会社ニデック | 475 cases |
| セイコーエプソン株式会社 | 230 cases |
| ソニーグループ株式会社 | 162 cases |
| 株式会社ニコン | 76 cases |
| オリンパス株式会社 | 21 cases |
Top company, Change in the Number of JP Patents
Below is a ranking of the number of JP patent applications by 眼’s top 7 coapplicants over the last 20 years.
Below is a patent map showing the changes in the numbers of JP patent filings by 眼’s top 7 coapplicants over the last 20 years.
Top company Details (JP)
Trends in filing of joint patent applications with キヤノン株式会社
眼 filed 489 joint applications with キヤノン株式会社 for the analysis period (2014 to 2024).
The mean of the number of filings over the last 5 years (2018 to 2023, 237 cases in total) is 39.5, and the median is 36.5. The coefficient of variation (standard deviation/mean) is 0.4, and there have been big fluctuations in the number of filings from year to year.
The number of filings has been decreasing for the last 3 years (2020 to 2023). The highest number of filings in 2014 with 81 cases, and their lowest number in 2020 with 33 cases.
| Index | Value |
|---|---|
| Average | 39.5 patents |
| Std Dev | 15.1 |
| COV | 0.4 |
| Year | Cases | YOY |
|---|---|---|
| 2022 year | 55 cases | -9.84 % |
| 2021 year | 61 cases | +84.8 % |
| 2020 year | 33 cases | -10.81 % |
Trends in filing of joint patent applications with 株式会社ニデック
眼 filed 475 joint applications with 株式会社ニデック for the analysis period (2014 to 2024).
The mean of the number of filings over the last 5 years (2018 to 2023, 206 cases in total) is 34.3, and the median is 32.5. The coefficient of variation (standard deviation/mean) is 0.4, and there have been big fluctuations in the number of filings from year to year.
The number of filings has been decreasing for the last 3 years (2020 to 2023). The highest number of filings in 2015 with 74 cases, and their lowest number in 2021 with 24 cases.
| Index | Value |
|---|---|
| Average | 34.3 patents |
| Std Dev | 13.5 |
| COV | 0.4 |
| Year | Cases | YOY |
|---|---|---|
| 2022 year | 25 cases | +4.17 % |
| 2021 year | 24 cases | -40.0 % |
| 2020 year | 40 cases | -2.44 % |
Trends in filing of joint patent applications with 株式会社トプコン
眼 filed 664 joint applications with 株式会社トプコン for the analysis period (2014 to 2024).
The mean of the number of filings over the last 5 years (2018 to 2023, 355 cases in total) is 59.2, and the median is 53.0. The coefficient of variation (standard deviation/mean) is 0.6, and there have been big fluctuations in the number of filings from year to year.
The highest number of filings in 2017 with 126 cases, and their lowest number in 2022 with 34 cases.
| Index | Value |
|---|---|
| Average | 59.2 patents |
| Std Dev | 32.7 |
| COV | 0.6 |
| Year | Cases | YOY |
|---|---|---|
| 2022 year | 34 cases | -15.00 % |
| 2021 year | 40 cases | -39.4 % |
| 2020 year | 66 cases | -8.33 % |
Trends in filing of joint patent applications with ソニーグループ株式会社
眼 filed 162 joint applications with ソニーグループ株式会社 for the analysis period (2014 to 2024).
The mean of the number of filings over the last 5 years (2018 to 2023, 63 cases in total) is 10.5, and the median is 12.0. The coefficient of variation (standard deviation/mean) is 0.8, and there have been relatively large fluctuations in the number of filings from year to year.
The number of filings has been decreasing for the last 3 years (2020 to 2023). The highest number of filings in 2014 with 38 cases, and their lowest number in 2022 with 0 cases.
| Index | Value |
|---|---|
| Average | 10.5 patents |
| Std Dev | 8.8 |
| COV | 0.8 |
| Year | Cases | YOY |
|---|---|---|
| 2021 year | 6 cases | -66.7 % |
| 2020 year | 18 cases | 0 |
| 2019 year | 18 cases | -14.29 % |
Trends in filing of joint patent applications with 株式会社ニコン
眼 filed 76 joint applications with 株式会社ニコン for the analysis period (2014 to 2024).
The mean of the number of filings over the last 5 years (2018 to 2023, 48 cases in total) is 8.0, and the median is 6.0. The coefficient of variation (standard deviation/mean) is 0.9, and there have been relatively large fluctuations in the number of filings from year to year.
The highest number of filings in 2018 with 18 cases, and their lowest number in 2022 with 0 cases.
| Index | Value |
|---|---|
| Average | 8.0 patents |
| Std Dev | 7.5 |
| COV | 0.9 |
| Year | Cases | YOY |
|---|---|---|
| 2021 year | 7 cases | +40.0 % |
| 2020 year | 5 cases | -72.2 % |
| 2019 year | 18 cases | 0 |
Information on important patents (JP)
The following shows JP patents held by 眼 that have had an invalidation trial against them demanded or an opposition filed against them by a third party, and 眼’s JP patents/patent applications of high importance cited by Examiners in patent examination processes.
By noting the most important patents, you can obtain knowledge of the competitive business environment in which 眼 is placed (e.g., whether it is a fiercely competitive environment or an oligopolistic market and the like). In general, it can be understood that a company with a large number of demands for invalidation trials is developing their business in a business environment where IP disputes are common.
If you want to search for more detailed information, you can use Patent Integration to retrieve and download by company cited patents/patent applications or patents undergoing invalidation trials. You can quickly extract important patents from a patent set that includes multiple competitors by cross-referencing with other keywords and patent classifications. Please consider using it for searches for important patents/patent applications.
Glossary
- Cited
- Indicates that the patent/patent application has been cited (by Examiners) in notices of reasons for rejection in the examination process of other (Japanese, U.S., or European) patent applications. The higher the number of citations, the more important the patent/patent application is considered to be.
- Request for invalidation trial
- Indicates that a third party has requested a procedure to invalidate the patent. It is likely to affect the business of third parties and is considered to be of high importance.
- Opposition
- Indicates that a third party has filed a petition with the Patent Office to hear the validity of the patent again. Like the trial for invalidation, it is considered to be of high importance.
- Information provision
- Indicates that a third party has provided the Patent Office with useful information for examination for the patent filed. It is usually considered to be of high importance because it is done to prevent the patent from being granted.
- Browsing request
- Indicates that a third party has requested the Patent Office to view the patent bag (a set of documents exchanged between the Patent Office and the applicant). The bag is often checked prior to trial for invalidation, opposition, and provision of information, and is considered to be a highly important patent.
Invalidationed Trial cases
List of latest Invalidationed Trial patents
In the last 3 years (2021-11-01 ~ 2024-10-31), there were 4 patents Invalidation Trial from third parties. The average number of Invalidation Trial is 1.0 times. The most recently Invalidation Trial patent is 特許7185426 "Ｓ１Ｐ受容体モジュレーターの投与計画" (Invalidation Trial day 2023-07-10) , next is 特許7118579 "エピナスチン又はその塩を含有する水性組成物" (Invalidation Trial day 2023-02-28) .
| - | No. | Title | Invalidation Trial days |
|---|---|---|---|
| 1 | 特許7185426 | Ｓ１Ｐ受容体モジュレーターの投与計画 | 2023-07-10 |
| 2 | 特許7118579 | エピナスチン又はその塩を含有する水性組成物 | 2023-02-28 |
| 3 | 特許7117438 | アレルギー性結膜炎治療剤 | 2023-01-12 |
| 4 | 特許6963651 | エピナスチン又はその塩を含有する水性組成物 | 2022-06-30 |
Top Patents/Patent Applications with the Highest Number of Invalidationed Trial
Of the patent applications filed in the last 10 years (2014-11-01 to 2024-10-31), 3 patents/patent applications were invalidation trial more than once in the examination process of other patent applications. The mean of the number of invalidation trial is 1.0. The most invalidation trial patent is 特許7117438 "アレルギー性結膜炎治療剤" (1 times) , and the next most invalidation trial patent is 特許6963651 "エピナスチン又はその塩を含有する水性組成物" (1 times) .
| - | No. | Title | |
|---|---|---|---|
| 1 | 特許7117438 | アレルギー性結膜炎治療剤 | 1 times |
| 2 | 特許6963651 | エピナスチン又はその塩を含有する水性組成物 | 1 times |
| 3 | 特許7118579 | エピナスチン又はその塩を含有する水性組成物 | 1 times |
Oppositioned cases
List of latest Oppositioned patents
In the last 3 years (2021-11-01 ~ 2024-10-31), there were 10 patents Opposition from third parties. The average number of Opposition is 1.0 times. The most recently Opposition patent is 特許7448953 "眼疾患のための細胞モデル及び治療関連出願への相互参照" (Opposition day 2024-04-17) , next is 特許7298844 "細胞培養物の製造方法" (Opposition day 2023-12-26) .
| - | No. | Title | Opposition days |
|---|---|---|---|
| 1 | 特許7448953 | 眼疾患のための細胞モデル及び治療関連出願への相互参照 | 2024-04-17 |
| 2 | 特許7298844 | 細胞培養物の製造方法 | 2023-12-26 |
| 3 | 特許7248627 | 遊技機 | 2023-09-22 |
| 4 | 特許7232927 | 眼鏡レンズおよびその製造方法 | 2023-09-04 |
| 5 | 特許7124791 | 塗工紙とその製造方法 | 2023-02-22 |
| 6 | 特許7075521 | 注射器 | 2022-11-25 |
| 7 | 特許7042954 | 注射器 | 2022-09-28 |
| 8 | 特許7026991 | 注射器 | 2022-09-01 |
| 9 | 特許7008337 | ヒト機能性角膜内皮細胞およびその応用 | 2022-08-09 |
| 10 | 特許6895380 | 治療免疫細胞の有効性を改良するための方法 | 2021-12-28 |
Protested cases
List of latest Protested patents
In the last 3 years (2021-11-01 ~ 2024-10-31), there were 29 patents Protest from third parties. The average number of Protest is 2.0 times. The most recently Protest patent is 特表2024-504870 "含窒素架橋複素環化合物、その調製方法及びその医薬的応用" (Protest day 2024-09-02) , next is 特開2023-168547 "眼科組成物" (Protest day 2024-06-26) .
| - | No. | Title | Protest days |
|---|---|---|---|
| 1 | 特表2024-504870 | 含窒素架橋複素環化合物、その調製方法及びその医薬的応用 | 2024-09-02 |
| 2 | 特開2023-168547 | 眼科組成物 | 2024-06-26 |
| 3 | 特開2023-029543 | 眼科用組成物 その３ | 2024-05-31 |
| 4 | 特開2022-001606 | エピナスチン又はその塩を含有する水性組成物 | 2024-05-31 |
| 5 | 特許7507655 | 立体フェイスマスク | 2024-05-01 |
| 6 | 特表2023-523851 | 可視領域及び近赤外領域において非常に低い反射率を有する光学物品 | 2024-04-10 |
| 7 | 特開2021-046394 | ブリモニジンとチモロールとを含む、緑内障罹患患者における眼圧を下降させるための組成物 | 2024-03-29 |
| 8 | 特開2023-052609 | 細胞培養物の製造方法 | 2024-01-23 |
| 9 | 特許7520285 | 高眼圧症及び緑内障を治療するための方法及び組成物 | 2023-11-28 |
| 10 | 特許7505888 | 眼科用組成物 | 2023-11-17 |
| 11 | 特許7471826 | 動画生成装置および動画生成プログラム | 2023-09-07 |
| 12 | 特開2023-093482 | Ｓ１Ｐ受容体モジュレーターの投与計画 | 2023-08-28 |
| 13 | 特開2022-180494 | 局所製剤 | 2023-06-17 |
| 14 | 特開2022-185062 | 点眼剤 | 2023-03-22 |
| 15 | 特許7434771 | 眼科装置、および眼科装置制御プログラム | 2023-03-08 |
| 16 | 特開2022-081491 | 注射器 | 2023-01-11 |
| 17 | 特許7320919 | 小さい活動性脈絡膜新生血管病変を有する加齢黄斑変性症の治療 | 2022-12-05 |
| 18 | 特開2019-123714 | 点眼剤 | 2022-11-15 |
| 19 | 特開2021-184827 | 注射器 | 2022-10-28 |
| 20 | 特開2021-042483 | 書籍用紙とその製造方法 | 2022-10-26 |
Top Patents/Patent Applications with the Highest Number of Protested
Of the patent applications filed in the last 10 years (2014-11-01 to 2024-10-31), 83 patents/patent applications were protest more than once in the examination process of other patent applications. The mean of the number of protest is 1.7. The most protest patent is 特許7320919 "小さい活動性脈絡膜新生血管病変を有する加齢黄斑変性症の治療" (10 times) , and the next most protest patent is 特許6523349 "掃引信号源光学コヒーレンスドメイン反射率測定用の装置" (7 times) .
| - | No. | Title | |
|---|---|---|---|
| 1 | 特許7320919 | 小さい活動性脈絡膜新生血管病変を有する加齢黄斑変性症の治療 | 10 times |
| 2 | 特許6523349 | 掃引信号源光学コヒーレンスドメイン反射率測定用の装置 | 7 times |
| 3 | 特開2017-061467 | 血管新生眼疾患を処置するためのＶＥＧＦアンタゴニストの使用 | 5 times |
| 4 | 特表2019-528113 | 機械学習モデルを使用した眼底画像の処理 | 5 times |
| 5 | 特許6073406 | 掃引信号源光学コヒーレンスドメイン反射率測定用の装置 | 5 times |
Inspectioned cases
List of latest Inspectioned patents
In the last 3 years (2021-11-01 ~ 2024-10-31), there were 159 patents Inspection from third parties. The average number of Inspection is 1.7 times. The most recently Inspection patent is 特表2024-524458 "トランスグルタミナーゼの阻害剤" (Inspection day 2024-09-19) , next is 特表2024-504870 "含窒素架橋複素環化合物、その調製方法及びその医薬的応用" (Inspection day 2024-09-12) .
| - | No. | Title | Inspection days |
|---|---|---|---|
| 1 | 特表2024-524458 | トランスグルタミナーゼの阻害剤 | 2024-09-19 |
| 2 | 特表2024-504870 | 含窒素架橋複素環化合物、その調製方法及びその医薬的応用 | 2024-09-12 |
| 3 | 特開2022-025105 | マスク | 2024-09-09 |
| 4 | 特開2022-153418 | 翻訳後修飾された完全ヒト抗ＶＥＧＦ Ｆａｂを用いる眼疾患の治療 | 2024-08-30 |
| 5 | 特表2023-518552 | ＬＮＰ０２３の結晶形態 | 2024-08-27 |
| 6 | 特表2023-548848 | ループスを処置するための方法および組成物 | 2024-08-14 |
| 7 | 特開2023-168547 | 眼科組成物 | 2024-07-23 |
| 8 | 特表2021-504375 | 医療用および美容用の逐次的に低強度音波にさらされるナノ粒子 | 2024-07-17 |
| 9 | 特開2022-084946 | 様々な疾患および障害の治療のためにＭＡＳＰ－１および／またはＭＡＳＰ－２および／またはＭＡＳＰ－３を阻害する組成物および方法 | 2024-07-11 |
| 10 | 特開2022-001606 | エピナスチン又はその塩を含有する水性組成物 | 2024-07-03 |
| 11 | 特許7007770 | 眼症状改善剤および眼症状の改善方法 | 2024-07-02 |
| 12 | 特表2021-515582 | 操作された細菌ユビキチンリガーゼ模倣物を用いる、幅広い範囲にわたるプロテオーム編集 | 2024-06-18 |
| 13 | 特表2021-503610 | 神経損傷および／または疾患のタンパク質バイオマーカー指標及びその使用の方法 | 2024-06-11 |
| 14 | 特開2022-105079 | 画像中の物体の視覚化および特徴づけのためのシステムおよび方法 | 2024-06-11 |
| 15 | 特表2023-525436 | ビグアニド系化合物、及びフラボン、ヒドロキシフラボン、フラバノン、フラボン誘導体、ヒドロキシフラボン誘導体、フラバノン誘導体の複合剤を有効成分として含有する癌の予防または治療用薬学的組成物 | 2024-06-10 |
| 16 | 特表2023-548856 | 眼用抗体薬物複合体 | 2024-06-05 |
| 17 | 特表2024-514870 | ムスカリン作動薬が結合したα２アドレナリン作動薬コドラッグ | 2024-06-05 |
| 18 | 特表2023-544853 | 局所眼科用組成物 | 2024-06-05 |
| 19 | 特開2023-029543 | 眼科用組成物 その３ | 2024-06-03 |
| 20 | 特開2021-046394 | ブリモニジンとチモロールとを含む、緑内障罹患患者における眼圧を下降させるための組成物 | 2024-05-31 |
Top Patents/Patent Applications with the Highest Number of Inspectioned
Of the patent applications filed in the last 10 years (2014-11-01 to 2024-10-31), 388 patents/patent applications were inspection more than once in the examination process of other patent applications. The mean of the number of inspection is 1.4. The most inspection patent is 特許7320919 "小さい活動性脈絡膜新生血管病変を有する加齢黄斑変性症の治療" (20 times) , and the next most inspection patent is 特許6487609 "点眼剤" (10 times) .
| - | No. | Title | |
|---|---|---|---|
| 1 | 特許7320919 | 小さい活動性脈絡膜新生血管病変を有する加齢黄斑変性症の治療 | 20 times |
| 2 | 特許6487609 | 点眼剤 | 10 times |
| 3 | 特開2019-123714 | 点眼剤 | 10 times |
| 4 | 特開2019-167366 | 血管新生眼疾患を処置するためのＶＥＧＦアンタゴニストの使用 | 10 times |
| 5 | 特開2017-002035 | ソフトコンタクトレンズが装用されたドライアイ患者の眼に点眼されるように用いられることを特徴とするドライアイ治療剤 | 8 times |
Cited cases
Top Patents/Patent Applications with the Highest Number of Cited
Of the patent applications filed in the last 10 years (2014-11-01 to 2024-10-31), 3,031 patents/patent applications were cited more than once in the examination process of other patent applications. The mean of the number of cited is 2.8. The most cited patent is 特許6598269 "導波管ディスプレイ" (85 times) , and the next most cited patent is 特許6895451 "偏光選択ホログラフィー導波管デバイスを提供するための方法および装置" (56 times) .
| - | No. | Title | |
|---|---|---|---|
| 1 | 特許6598269 | 導波管ディスプレイ | 85 times |
| 2 | 特許6895451 | 偏光選択ホログラフィー導波管デバイスを提供するための方法および装置 | 56 times |
| 3 | 特開2017-138846 | 情報処理装置、その表示方法、及びコンピュータが実行可能なプログラム | 54 times |
| 4 | 特許6646659 | 仮想および拡張現実を作成する方法およびシステム | 49 times |
| 5 | 特表2017-500605 | 仮想現実および拡張現実のシステムおよび方法 | 47 times |
Providing patent information to the media (newspapers, magazines, etc.)
"Patent Integration Report" is a web service provided by "Patent Integration Co., Ltd." operated by patent attorneys who are experts in intellectual property rights. Based on the latest patent data, this is one of the largest patent report services in Japan that provides information on technology trends in various companies and technology fields.
The purpose of this web service is to make intellectual property information familiar to many people, regardless of whether they have an interest in intellectual property rights, and to make use of it.
We actively provide various types of patent information that can be used in various media articles such as newspapers, magazines, and web media. Please feel free to contact us from "Inquiry form for details on the content of patent information that can be provided, conditions for provision, etc. Please contact us.
About this Site
All rights related to the data, documents and charts belong to "an integrated patent search/analysis service provider, Patent Integration". Please specify the source “Patent Integration Report, URL: https://patent-i.com/report/en/" when inserting them into in-house materials, external report materials, etc., regardless of whether they are paid or free of charge.
Patent data is obtained by aggregating and analyzing the latest patent data issued by the Patent Offices of respective countries and jurisdictions and by WIPO. Although we take great care in publishing and analyzing the results, we do not guarantee the correctness of the data. We appreciate your understanding.
If you have any concerns about this service, please feel free to contact us.
All rights to the data, documents, figures and tables are reserved by e-Patent. When publishing internal documents, external reports, etc. (whether paid or free of charge), please use the following URL: https://e-patent.co.jp/.
Please note the following points for use.
e-Patent will not be liable for any damages or losses arising from the use of the global patent application status, ranking information, or population search formula in the "SDGs Global Company Ranking from a Patent Perspective". Items with ● in front of the target are not supported at this time (judged to be difficult to approach from the patent information analysis).
Citation of patent application status and ranking information
There is no problem to cite patent application status and ranking information, but please clearly indicate "Source: e-Patent Co.
Graphs are image data.
Please note that the various graphs are image data, but we cannot provide them in text data.Scope of coverage for each goal/target
- Based on the description of each goal and target of the SDGs, we have set the scope of technologies to be covered based on our and e-Patent's past experience, etc. (in some cases, the search is based on social issues themselves). Therefore, please note that there is a possibility that this "SDGs Global Company Ranking from Patent Perspective" may not cover 100%.
- A population search formula is clearly indicated for each goal/target (database: Patent Integration). You may use the population search formula as it is, or you may improve it by yourself.
- This search covers patents and utility models, including both published and registered patents (design and design patents are excluded). The unit of count is the number of applications, not the number of patent families.
About the name collation and name control of applicants and right holders
- Company rankings are based on the results calculated by "Patent Integration", with Japanese organizations in Japanese and other companies in English (some are in Japanese).
- Company names may be the names of the companies at the time of application, but the results calculated by Patent Integration are used as is. Company names are used as they were at the time of application.
- Because of the fluctuation in the names of companies (i.e., applicant/right holder names in the patent information), there are cases where the same company appears more than once in the top 10. The number of applications filed by the same company in the top 10 is the total number of applications filed by the company.
Credit notation
・MeCab user dictionary for science technology term © National Bioscience Database Center licensed under CC Attribution-Share Alike 4.0 International
Our Commitment to Safety and Security
Patent Integration Co., Ltd. is committed to providing high-quality patent information based on the latest patent data on more than 45 million cases collected from the Patent Offices in Japan, the U.S., Europe, and Taiwan and from PCT publication. 
Patent Integration Co., Ltd. collects the patent data from the Patent Offices in Japan, the U.S., Europe, and Taiwan and from PCT publications to provide it widely in the form of reports so that anyone can check patent information and patent trends with confidence. 
Patent Integration Co., Ltd. is committed to various efforts to enhance the reliability of the information and to allow users to search patent information with confidence.